Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 6.38 M5.54 M4.61 M4.34 M 20.88 M Research & development ———— — Operating income 46.7 M46.27 M43.45 M91.83 M 228.25 M Non-Operating Income, Total -28 M-37.78 M-10.12 M-231.95 M -307.86 M Interest expense, net of interest capitalized 37.02 M38.82 M49.52 M52.51 M 177.88 M Non-Operating Income, excl. Interest Expenses -65.03 M-76.6 M-59.65 M-284.46 M -485.73 M Unusual income/expense ———— — Pretax income -18.59 M-31.66 M-17.04 M-193.53 M -260.82 M Equity in earnings ———— — Taxes ———— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 18.7 M8.49 M33.32 M-140.12 M -79.61 M Discontinued operations ———— — Net income 18.7 M8.49 M33.32 M-140.12 M -79.61 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 18.7 M8.49 M33.32 M-140.12 M -79.61 M Basic earnings per share (Basic EPS) ———— — Diluted earnings per share (Diluted EPS) ———— — Average basic shares outstanding ———— — Diluted shares outstanding ———— — EBITDA 83.32 M91.82 M107.97 M152.08 M 435.19 M EBIT 46.7 M46.27 M43.45 M91.83 M 228.25 M Cost of revenue 35.17 M42.92 M50.03 M56.09 M 184.22 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 36.62 M45.55 M64.52 M60.25 M 206.94 M